eNews May 11, 2021The latest news affecting you and your customers… from the Independent Medical Specialty Dealers Association
How is COVID-19 affecting your business, your people, your customers? IMDA is a membership organization, and in times like these, we can all use some camaraderie. If you have a COVID story to share, advice to offer, or a warning to sound, send it to Mark Thill, IMDA’s communications director, at email@example.com, with the subject line “IMDA COVID story.” We’ll compile them and send them back out to you.
FDA inspections to resume
Let your manufacturer partners know: The U.S. Food and Drug Administration is on the road again, with plans to resume normal inspectional activities following the COVID-19-related slowdown. In a new report, Resiliency Roadmap for FDA Inspectional Oversight, the agency outlines how it intends to prioritize domestic and foreign inspections that were not performed during the pandemic. Inspections considered critical to the FDA’s mission will remain the primary focus. When planning routine surveillance inspections, the agency will prioritize higher-risk establishments.
Monitor for orthopedic emergencies
Montreal, Quebec-based MY01 received 510(k) clearance to market its Continuous Compartment Pressure Monitor with full Bluetooth capabilities. The monitor is said to deliver a reliable, accurate continuous pressure microsensor directly within the muscle. Trauma is the most common cause of Acute Compartment Syndrome (ACS), according to the company. Following trauma, swelling may build up, causing an increase in muscle pressure leading to ACS. Rapid diagnosis followed by prompt surgical decompression via a fasciotomy is critical to achieving favorable patient outcomes. In the U.S., an estimated 500,000 cases per year could be at-risk of Compartment Syndrome.
BD to spin off diabetes business
BD expects its spinoff of the company’s Diabetes Care business as an independent, publicly traded company to be completed in the first half of 2022. The Diabetes Care business produces approximately 8 billion diabetes injection devices annually. Following the spinoff, BD will maintain its portfolios in the BD Medical, BD Life Sciences and BD Interventional segments.
AARC has new VP of education and meetings
Lanny Inabnit, MS, RRT, RRT-ACCS, RRT-NPS, RCP, FAARC, will join the American Association for Respiratory Care as the new vice president of educating and meetings. Inabnit graduated from Southern Illinois University with an Associate in Applied Science in Respiratory Therapy Technology in December 1994. He was hired as a clinical assistant professor in the Bachelor of Science in Respiratory Care Degree Completion Program at UNC-Charlotte in 2014. In 2018, he transitioned to a remote clinical assistant professor in the Department of Respiratory Care at Boise State University to work in its Degree Advancement Bachelor of Science Respiratory Care program.
Walmart, Amazon: Unlikely healthcare competitors
Walmart purchased telehealth provider MeMD and plans to offer nationwide virtual healthcare services, reports The Wall Street Journal. The deal opens another front in which Walmart and Amazon will compete, as Amazon recently announced plans to provide its telehealth service, Amazon Care, to nearly one million U.S. employees by summer. Amazon Care, which now serves company workers in Washington state, will also be offered to other employers.
YOU’RE WORTH IT
Learn how to clarify and articulate your return-on-investment for your manufacturers and customers at this fall’s 2021 IMDA/HIRA Annual Conference, “ROI: It’s More Than Just Money,” Sept. 27-29, in suburban Chicago. You know you’re worth it. Now let everyone else know it too!